Health Care " BioVaxys (CSE:BIOV) reports progress on a universal SARS vaccine BioVaxys (BIOV) and Ohio State University report progress on a universal vaccine to treat a range of SARS viruses. Caroline Egan2 mins03 June 2022 15:45 (EDT)
Health Care Sponsored The Power Play " BioVaxys (CSE:BIOV) expands cancer vaccine platform BioVaxys Technology Corp. (BIOV) has expanded its cancer vaccine platform with BVX-0922, its autologous haptenized tumor vaccine for colorectal cancer. John Ballem1 min30 March 2022 13:45 (EDT)
Sponsored Weekly Market Movers " Top 5 Stories of the Week: Odd Burger (TSXV:ODD), X-Terra Resources (TSXV:XTT), BioVaxys (CSE:BIOV), Monarch Mining (TSX:GBAR), Trillion Energy (CSE:TCF) The week in Canadian markets is ending with a sense of trepidation for stocks in the near term. Trevor Abes5 mins10 February 2022 12:45 (EDT)
